Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurosarcoidosis.

Ashok V Patel1, David E Stickler, William R Tyor

  • 1William R. Tyor, MD Neurology Service, Ralph H. Johnson VA Medical Center, 109 Bee Street, Charleston, SC 29401, USA. tyorwr@musc.edu.

Current Treatment Options in Neurology
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.

Journal of neurovirology·2020
Same author

HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.

Scientific reports·2020
Same author

CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2019
Same author

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.

Journal of neuroinflammation·2019
Same author

Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.

Scientific reports·2019
Same author

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia.

Frontiers in immunology·2019

Neurosarcoidosis diagnosis requires careful evaluation. While glucocorticoids are a primary treatment, alternative therapies exist for refractory cases, offering hope for improved patient outcomes.

Area of Science:

  • Neurology
  • Immunology
  • Rare Diseases

Background:

  • Neurosarcoidosis is an uncommon neurological disorder.
  • Diagnosis relies on thorough clinical assessment.
  • Peripheral symptoms generally correlate with better prognoses than central nervous system involvement.

Purpose of the Study:

  • To summarize the clinical presentation, diagnosis, and management of neurosarcoidosis.
  • To highlight treatment responses and alternative therapeutic options.

Main Methods:

  • Review of clinical findings in neurosarcoidosis patients.
  • Analysis of treatment outcomes with glucocorticoids and alternative immunosuppressants.

Main Results:

  • Peripheral neurosarcoidosis symptoms often indicate a better prognosis.

Related Experiment Videos

  • Central nervous system involvement, mass lesions, or hydrocephalus may predict poorer outcomes and treatment resistance.
  • Glucocorticoids typically yield rapid responses, with maintenance and slow tapering being standard.
  • Various alternative agents are available for refractory cases or steroid-sparing strategies.

    • Conclusions:

    • Neurosarcoidosis management requires individualized treatment plans.
    • Early diagnosis and appropriate therapy are crucial for managing this complex neurological condition.
    • A range of immunosuppressive agents can be utilized for refractory or steroid-intolerant patients.